ABPA Overview and Management
Your patient likely has a bacterial pneumonia superimposed on underlying asthma, NOT active ABPA—that IgE of 28 U/mL is way too low to meet diagnostic criteria for ABPA, which requires total IgE >1000 IU/mL (or >500 IU/mL in some contexts). 1
What the Hell is ABPA?
Allergic Bronchopulmonary Aspergillosis is a hypersensitivity lung disease caused by an exaggerated type 2 immune response to Aspergillus fumigatus colonizing the airways. It's NOT an infection—it's an allergic/immunologic overreaction in susceptible people (usually asthmatics). 2
Key pathophysiology:
- Aspergillus spores colonize airways → massive IgE and IgG antibody production
- Eosinophilic inflammation causes mucus plugging and airway damage
- Over time: central bronchiectasis, fibrosis, respiratory failure
Diagnostic Criteria (2024 ISHAM Guidelines)
To diagnose ABPA, you need ALL of these: 1
- Predisposing condition: Asthma or cystic fibrosis
- Immunologic criteria (both required):
- Total IgE >1000 IU/mL (or >500 IU/mL with other strong features)
- Aspergillus fumigatus-specific IgE elevated
- Plus at least 2 of 3:
- A. fumigatus-specific IgG elevated or positive precipitins
- Eosinophilia (>500 cells/μL)
- Imaging: central bronchiectasis, mucus plugging, or high-attenuation mucus
Your patient's IgE of 28 is nowhere near the threshold—this essentially rules out ABPA. The "upper range 50" you mention is likely a lab reference range for normal, not the diagnostic cutoff for ABPA.
Why Your Patient Probably Doesn't Have ABPA
- IgE 28 U/mL is NORMAL, not elevated
- ABPA patients typically have IgE >1000 IU/mL, often >2000-5000 IU/mL 3, 4
- The pneumonia is likely bacterial/infectious, not ABPA-related
Critical pitfall: ABPA is frequently misdiagnosed as recurrent pneumonia, but the reverse is also true—don't force an ABPA diagnosis when the serology doesn't fit. 3, 4
If This Actually Were ABPA (Hypothetically)
First-Line Treatment Options 1
Choose ONE of these for acute ABPA:
Oral Prednisolone (most rapid-acting):
- 0.5 mg/kg/day for 2-4 weeks
- Taper over 4 months total duration
- Faster symptom control but more side effects
Oral Itraconazole (safer, slower):
- 400 mg/day divided BID × 4 months (with meals)
- Check trough levels (target ≥0.5 mg/L)
- Similar efficacy to steroids but takes longer
Key guideline recommendation: Do NOT routinely combine prednisolone + itraconazole as first-line therapy—no benefit over monotherapy and more adverse events. 1
When to Treat vs. Observe 1
DO treat if:
- Symptomatic ABPA with respiratory symptoms
- Poor asthma control despite optimal therapy
- Radiologic progression (bronchiectasis, mucus plugging)
DON'T treat if:
- Asymptomatic serologic ABPA (ABPA-S) with well-controlled asthma
- Just monitor q3-6 months with IgE, imaging, clinical assessment
Monitoring Treatment Response 1
Response criteria at 8 weeks:
- ≥50% symptom improvement
- IgE decline ≥20% from baseline
- Major radiologic improvement (>50% reduction in opacities)
Exacerbation defined as: 1
- Sustained worsening >14 days
- IgE increase ≥50% from stable baseline
- New/worsening infiltrates on imaging
- Must exclude bacterial infection/bronchiectasis exacerbation
What to Actually Do for Your Patient
- Treat the pneumonia with appropriate antibiotics based on severity and local resistance patterns
- Optimize asthma management with inhaled corticosteroids ± bronchodilators
- Don't start ABPA-specific therapy given the normal IgE
- Consider ABPA workup IF:
- Recurrent pneumonias despite treatment
- Poor asthma control with eosinophilia
- Central bronchiectasis on CT
- Then check: total IgE, Aspergillus-specific IgE/IgG, eosinophil count
Critical Pitfalls to Avoid
- Don't diagnose ABPA with normal IgE—you need >1000 IU/mL (or at minimum >500 IU/mL with strong supporting features)
- Don't confuse ABPA exacerbation with bacterial pneumonia—check IgE trends and imaging; bacterial infections cause purulent sputum, fever, and don't cause IgE spikes 1
- Don't use high-dose inhaled steroids alone for acute ABPA—they don't work 1
- Don't forget CT chest—central bronchiectasis is the hallmark finding and predicts recurrent exacerbations 1